Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESTOPRIM: transdermal testosterone pretreatment in poor ovarian response
2016-004302-33Phase 3Completed
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of testosterone in female infertility, poor ovarian response (POR), sponsored by Health Research Institute Hospital La Fe. Started Jan 2017; status: completed.
02
Drugs
testosterone
03
Conditions
female infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on 2016-004302-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004302-33.